Ensysce Share Price

Ensysce Share Price

NASDAQ: ENSC | Micro Cap | Healthcare
$0.37
-$0.01 (-3.05%) Last updated on 19 Nov, 2026 | 01:12 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Ensysce Stock Performance

Open
$0.38
Prev. Close
$0.38
Circuit Range
N/A
Day Range
$0.38 - $0.38
Year Range
$0.23 - $1.89
Volume
663
Average Traded
$0.38

Ensysce Share Price Today

As of 19 November 2026, Ensysce Biosciences, Inc.'s share price is $0.37. The stock opened at $0.38, compared to its previous close of $0.38. During today's trading session, Ensysce Biosciences, Inc.'s share price traded between $0.38 and $0.38, with an average price of $0.38. Over the past 52 weeks, the stock has recorded a high of $1.89 and a low of $0.23. In terms of performance, Ensysce Biosciences, Inc.'s share price has risen by 30.78% over the last six months and is down 79.16% on a year-on-year basis.

Ensysce Share Price Chart

Line chart of the Ensysce price trend over the selected period. The price fell overall, ranging from 0.37 to 0.39, ending at 0.37.
$0.38$0.38
L
Show Current Price
H

Ensysce Stock Fundamentals & Key Indicators

Market Cap
$943160.64
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-4.69
Revenue (TTM)
$5.07B
Return On Equity (TTM)
-332.40%
Profit Margin
-200.79%
Debt to Equity
0.01
Quarterly Earnings Growth YoY
-2871.84%

Ensysce Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$1.88$0.96$1.16$2.18
Net Profit-$2.77-$3.56-$2.57-$82.32
Net Profit Margin-147.34%-370.83%-221.55%-3776.15%
Income ChangeN/A-28.52%27.81%-3103.11%

Ensysce Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$2.52$2.23$5.21$5.07
Net Profit-$25.09-$10.63-$7.99-$10.18
Net Profit Margin-995.63%-476.68%-153.36%-200.79%
Income ChangeN/A57.63%24.84%-27.41%

Ensysce Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.210.250.420.59
Current Assets7.255.342.295.3
Total Assets7.455.62.715.89
Non Current Liabilities0.00.010.030.45
Current Liabilities4.572.213.339.46
Total Liabilities4.572.223.369.91
Shareholders' Equity2.883.38-0.65-4.03

Ensysce Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-7.81-7.5-10.78-17.89
Investing-0.120.00.00.0
Financing8.749.888.768.77

Corporate Actions

Split
Ex-date: 06 Dec 2024

Split
Ex-date: 31 Mar 2023

Split
Ex-date: 28 Oct 2022

About Ensysce

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Ensysce Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.40
$0.38
-10.45%
Oct 2026
$0.42
$0.42
+0.48%
Sep 2026
$0.39
$0.42
+5.28%
Aug 2026
$0.26
$0.40
+54.26%
Jul 2026
$0.30
$0.26
-10.10%
Jun 2026
$0.27
$0.29
+1.77%
May 2026
$0.35
$0.28
-25.59%
Apr 2026
$0.57
$0.38
-31.09%
Mar 2026
$0.54
$0.55
-12.00%
Feb 2026
$0.69
$0.63
-13.91%
Jan 2026
$0.90
$0.73
-21.34%
Dec 2025
$1.79
$0.92
-47.85%

Ensysce Share Price FAQs